Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells

Bulletin of Experimental Biology and Medicine

Volumn 140, Issue 1, 2005, Pages 88-91

  Bershtein, L M ^a   Levina, V V ^b   Poroshina, T E ^a   Tsyrlina, E V ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

8 hydroxy 2 deoxyguanosine; Breast cancer; Estrogen and progesterone receptors; MCF 7 cell line

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BETA NAPHTHOFLAVONE; ESTRADIOL; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MARKER; DNA DAMAGE; FEMALE; FOLLOW UP; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; STAINING; STATISTICAL SIGNIFICANCE;

BETA-NAPHTHOFLAVONE; BREAST NEOPLASMS; DEOXYGUANOSINE; DNA DAMAGE; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTAGENICITY TESTS; RECEPTORS, STEROID;

MINK CELL FOCUS-FORMING VIRUS;

EID: 27644566792     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-005-0419-7     Document Type: Article

References (14)

1. L. M. Bershtein, Oncoendocrinology: Traditions, Contemporaneity, and Perspectives [in Russian], St. Petersburg (2004).
2. L. M. Bershtein, E. V. Tsyrlina, I. G. Kovalenko, et al., Vopr. Onkol. 48, No.4, 49-52 (2002).
3. N. E. Kushlinskii and E. S. Gershtein, Vestn. Ros. Akad. Med. Nauk, No. 9, 65-70 (2001).
4. V. F. Semiglazov, K. Sh. Nurgaziev, and A. S. Arzumanov, Breast Tumors (Therapy and Prevention) [in Russian], Almaty (2001).
5. E. V. Tsyrlina, V. M. Moiseenko, T. R. Boronoeva, and V. F. Semiglazov, Vopr. Onkol., 30, No.4, 29-33 (1984).
6. Advances in Endocrine Therapy of Breast Cancer, Eds. J. Ingle and M. Dowsett, New York (2004).
7. N. R. Bianco, G. Perry, M. A. Smith, et al., Mol. Endocrinol., 17, 1344-1355 (2003). 10.1210/me.2002-0382
8. E. Cavalieri, K. Frenkel, J. G. Liehr, et al., J. Natl. Cancer Inst. Monograph, 27, 75-94 (2000).
9. S. A. Khan, M. A. Rogers, K. K. Khurana, et al., J. Natl. Cancer Inst., 90, 37-42 (1998). 10.1093/jnci/90.1.37
10. J. Musarrat, J. Arezina-Wilson, and A. A. Wani, Eur. J. Cancer, 32A, 1209-1214 (1996). 10.1016/0959-8049(96)00031-7
11. J. Quong, S. Eppenberger-Castori, D. Moore, et al., Breast Cancer Res. Treat., 76, 221-236 (2002). 10.1023/A:1020886801674
12. M. Saez, P. Martin, and C. D. Chouvet, Cancer Res., 38, 3468-3473 (1978). 688231
13. S. H. Safe, L. Pallaroni, K. Yoon, et al., Environ. Health Perspect., 110, Suppl. 6, 925-929 (2002). 12634121
14. Y. Yasui and J. Potter, Cancer Causes ControL, 10, 431-437 (1999). 10.1023/A:1008970121595